The Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
Department of Ophthalmology, Gui De Chauliac Hospital, Montpellier, France.
Clin Exp Ophthalmol. 2018 Apr;46(3):266-274. doi: 10.1111/ceo.13038. Epub 2017 Oct 4.
Identifying variables that influence presenting visual acuity (VA) in patients with neovascular age-related macular degeneration (nAMD) is important because it is a strong predictor of long-term outcomes.
To assess the clinical and social characteristics associated with low presenting VA in nAMD patients.
The present study is a cross-sectional analysis from a prospective, observational database.
We identified 3242 treatment-naïve patients from 54 Australian practices in the Fight Retinal Blindness! registry.
Age, gender, ethnicity and VA were recorded at the baseline visit. Socio-economic status was determined using the Australian Bureau of Statistics socio-economic indexes for areas.
Association between clinical and socio-economic characteristics with presenting VA was identified.
Poor VA (≤35 letters) in the presenting eye was associated with older age (adjusted odds ratio [AOR]: 1.33 for patients aged ≥80 years vs. <80 years [95% confidence interval, CI: 1.04, 1.71]), treatment at a public practice (AOR: 1.91 for public vs. private practices [95% CI: 1.46, 2.50]) and intermediate (36-69 letters) VA in the fellow eye (AOR: 0.67 [95% CI: 0.47, 0.95] and 0.64 [95% CI: 0.48, 0.85] for poor [≤35 letters] and good [≥70 letters] VA vs. intermediate VA in the fellow eye). Gender, ethnicity and socio-economic status were not independently associated with VA at presentation.
Poor presenting vision is detrimental to the long-term outcomes of nAMD. Poor presentation of nAMD in Australia may not be related to socio-economic circumstances, but due to systems of care. Further research is warranted to determine why patients at public practices present with worse vision compared with private practices in Australia.
识别影响新生血管性年龄相关性黄斑变性(nAMD)患者表现视力(VA)的变量很重要,因为它是长期预后的强有力预测指标。
评估与 nAMD 患者低表现 VA 相关的临床和社会特征。
本研究是一项来自前瞻性观察性数据库的横断面分析。
我们从“抗击视网膜盲!”登记处的 54 家澳大利亚实践中确定了 3242 名未经治疗的初治患者。
在基线就诊时记录年龄、性别、种族和 VA。使用澳大利亚统计局的区域社会经济指数确定社会经济地位。
确定临床和社会经济特征与表现 VA 之间的关联。
初诊眼视力差(≤35 个字母)与年龄较大(调整后的优势比 [AOR]:≥80 岁患者为 1.33 [95%置信区间,CI:1.04,1.71]与<80 岁患者相比)、在公立医院接受治疗(AOR:公立医院为 1.91 与私立实践[95%CI:1.46,2.50])和对侧眼中等视力(36-69 个字母)(AOR:0.67 [95%CI:0.47,0.95]和 0.64 [95%CI:0.48,0.85]对于对侧眼较差[≤35 个字母]和较好[≥70 个字母]VA 与中等 VA)相关。性别、种族和社会经济地位与表现时的 VA 无独立相关性。
较差的初始视力对 nAMD 的长期预后不利。澳大利亚 nAMD 的表现不佳可能与社会经济环境无关,而是与护理系统有关。需要进一步研究以确定为什么澳大利亚公立医院的患者与私立医院相比,表现出更差的视力。